Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Clinical
Phase I
Phase I
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase I
Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma
Firstwordpharma News
-
January 13, 2020
Phase I
Ultragenyx Announces Positive Topline Cohort 3 Results and Improved Longer-Term Cohort 2 Results from Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase...
Phase I
BioXcel Therapeutics Announces First Patient Enrolled in Phase 1b/2 Study of BXCL501 for Acute Treatment of Agitation Associated with Dementia
Phase I
BioMarin Announces New England Journal of Medicine Publishes 3 Years of Follow-up Data in Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Hemophilia...
Phase I
BioMarin Announces New England Journal of Medicine Publishes 3 Years of Follow-up Data in Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Hemophilia...
Phase I
First Patient Dosed in Phase 1 Clinical Study of Tafasitamab in...
Firstwordpharma News
-
December 27, 2019
0
Phase I
OBI Pharma Announces Initiation of a Phase 1/2 Study of Its...
Biospace News
-
December 18, 2019
0
Phase I
REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for...
Firstwordpharma News
-
December 18, 2019
0
Phase I
?NeuClone Completes Dosing in Phase I Clinical Trial of Stelara (ustekinumab)...
Firstwordpharma News
-
December 18, 2019
0
Phase I
Poxel Announces Positive Results for PXL065 Phase 1b Trial and Provides...
Biospace News
-
December 18, 2019
0
1
2
3
...
24
Page 1 of 24
- Advertisement -
MOST POPULAR
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for...
May 13, 2019
AOBiome Doses First Patient in Phase 1b Clinical Trial of B244...
March 6, 2019
RespireRx Pharmaceuticals Inc. and Impression Healthcare Limited Announce Agreement to Explore...
February 19, 2019
Cell Medica Awarded USD 8.7 Million CPRIT Grant to Accelerate CMD-502...
February 26, 2019
Load more
HOT NEWS
Others
United Nations strengthens Ebola response in Democratic Republic of the Congo
Phase I
Auris Medical Reaches Midpoint for Enrollment in AM-201 Phase 1b Proof-of-Concept...
Commercial
Actelion, a J&J Division, Ponies up $360 Million to Settle U.S....
Commercial
Omeros Corporation Announces Upcoming Educational Event at the Annual Meeting of...
